Navigation Links
Escherichia coli C600

1,900 V Time constant (T) 5 ms
  • Immediately add 1 ml SOC medium and transfer to a sterile culture tube with a pasteur pipette. Incubate 30-
    60 minutes with moderate shaking at 37 C.
  • Plate on LB plates containing the appropriate selection chemical.
    • Expected Results: Transformation efficiency up to 2 x 109 transformants/g of DNA.


    '"/>

    Source:


    Page: All 1 2 3

    Related biology technology :

    1. Escherichia coli C600
    2. Escherichia coli DH10B
    3. Escherichia coli DH5
    4. Escherichia coli K12
    5. Escherichia coli K12
    6. Escherichia coli DH10B
    7. Escherichia coli DH5

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    		TAG: Escherichia coli

    (Date:11/5/2009)...., Nov. 5 Transgenomic, ...nancial results for the quarter ended September 30...ted in the tables that follow. ,, Third Quarte...366,000 or $0.01 per share for the third quarter o....01 per share for the third quarter of 2008. ,...
    (Date:11/5/2009)...alif., Nov. 5 WaferGen B...ing developer of state-of-the-art genetic analysis...Ph.D. has joined the company,s Scientific Advisory...and commercializing novel molecular diagnostics fo...the development of computational biology systems f...
    (Date:11/5/2009)... Brooke Sanders brings a new look to Pro ...) November 5, 2009 -- Professional Reprographics, ...s company is pleased to present Brooke Sanders to ...phics/PR specialist. The addition of Brooke to the...h within Professional Reprographics., , ,Brooke br...
    (Date:11/4/2009)...ROCKVILLE, Md., Nov. 4 Zyngenia, I...sed on next-generation antibody drug development, ... Series A funding from New Enterprise Associates (...irms. The capital will be used to create novel, mu...two or more biological targets with a single agent...
    Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
    ...WALTHAM, Mass., Sept. 17 Repligen Corporation,(Na...sident and Chief,Executive Officer, Walter C. Herl...fe Sciences Conference on Wednesday, September 24,...55 Madison Avenue, New York, NY., A live audio-we...pligen,s website at http://www.repligen.com and ...
    ...Addition of metabolite technology uniquely positio...f predictive diagnostic tests, EMERYVILLE, Calif....y that it has acquired Lipomics Technologies of We...lized today upon completion,of customary closing c...he acquisition brings together Lipomics, metabolit...
    ...SAN DIEGO, Sept. 17 Ardea Biosciences, Inc.,(Nasd...harmD, President and,CEO of Ardea Biosciences, wil... UBS Global Life Sciences Conference, Date: Wed...ern Time Location: Grand Hyatt, New York Web...Securities Healthcare Focus Conference, Date: T...
    Other Biology Technology:Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT 2Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT 3Tethys Bioscience Announces Acquisition of Lipomics Technologies 2Tethys Bioscience Announces Acquisition of Lipomics Technologies 3Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference 2
    (Date:11/4/2009)... natural science) , United States Using Less W...today than it did 35 years ago, despite a 30 perce...partly attributable to alternative cooling methods...tems. According to the latest USGS water use repor...tes goes to cooling thermoelectric power plants. I...
    (Date:11/4/2009)...ry that deciphered the DNA codes, or genomes, of t...has joined The Genome 10K Project, an internationa...sequences on 10,000 species of animals for conduct...can not be achieved. , Participating in The Geno...the Nov. 5, 2009 issue of the Journal of Heredity...
    (Date:11/4/2009)...f., Oct. 20 DigitalPersona, Inc., ...n solutions, today announced that WAND Corporation...re for quick-service restaurants, has integrated D...d Classic POS solutions. WAND,s quick-service cust...cashier accountability and deter unauthorized mana...
    Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Blood Sugar Spikes Send Testosterone Levels Down 48816 1Blood Sugar Spikes Send Testosterone Levels Down 48816 2Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 1Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 2Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 3Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 4Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 1Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 2Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 3Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 4
    ...ing advanced new microscopy techniques in concert ...ists at The Wistar Institute have for the first ti...owing immune cells targeting cancer cells in live ...ls called T cells can be seen actively migrating t...lls, and killing them. , Insights from this new v...
    ...ochemists at Oregon State University have develope...ription factors" that help steer stem cells into f...ake up all the organs and parts of a living verte... embryonic spinal cord as a model, and will be ann...ademy of Sciences, a professional journal. , The...
    ...protein naturally occurring in the brain improves ...s after the onset of the stroke, and could be used...ished today in the open access journal BMC Biology...mulating Factor (G-CSF), whose function in the bra...teract neurone death, reduces the size of the area...
    Other Biology News:Innovative movies show real-time immune-cell activity within tumors 2Innovative movies show real-time immune-cell activity within tumors 3Advance helps explain stem cell behavior 2Advance helps explain stem cell behavior 3Brain protein improves stroke symptoms in rats, even when injected after 3 days 2
    10X BlueJuice Gel Loading Buffer from Invitrogen
    Genetic Mapping of Disease Genes from Promega
    HTP Zero Blunt TOPO PCR Cloning Kit for Sequencing MultiShot E. coli from Invitrogen
    HTP Zero Blunt TOPO PCR Cloning Kit for Sequencing MultiShot StripWell E. coli from Invitrogen
    Biology Products: